J&J Device Sales Growth Led By Diabetes, Vision Care As Q4 Stent Sales Sink

Johnson & Johnson's diabetes and vision care businesses generated the highest growth levels across the firm's device sector in the fourth quarter with each achieving operational growth of 12% compared to a year ago, the firm reported Jan. 23